Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: ("novell" OR "novelle")
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Search alternatives
:
"novell" »
"novels"
,
"lovell"
,
"novellen"
"novelle" »
"novelse"
,
"lovelle"
,
"novellene"
Showing
1
-
17
of
17
Search:
'("novell" OR "novelle")'
,
query time: 0.08s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Management of relapsing-remitting multiple sclerosis
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
..., are not well-established. The emergence of
novel
oral and injectable agents necessitates consideration...
”
Read Now
2
Management of relapsing-remitting multiple sclerosis
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
..., are not well-established. The emergence of
novel
oral and injectable agents necessitates consideration...
”
Read Now
3
Clinical review report: Obeticholic acid (Ocaliva) : (Intercept Pharmaceuticals Canada, Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... receptor agonist. Farnesoid receptors are a
novel
pharmacological target, and stimulation...
”
Read Now
4
Clinical review report: Obeticholic acid (Ocaliva) : (Intercept Pharmaceuticals Canada, Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... receptor agonist. Farnesoid receptors are a
novel
pharmacological target, and stimulation...
”
Read Now
5
Bioabsorbable stents for adults with coronary artery disease : a review of the clinical effectiveness, cost-effectiveness, and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... or hypersensitivity reactions, and
novel
anti-proliferative agents....
”
Read Now
6
Bioabsorbable stents for adults with coronary artery disease : a review of the clinical effectiveness, cost-effectiveness, and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... or hypersensitivity reactions, and
novel
anti-proliferative agents....
”
Read Now
7
Ceftolozane and tazobactam for the treatment of bacterial infections : a review of clinical effectiveness, cost-effectiveness, and guidelines
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... recently developed antimicrobia l therapy is the fixed-dose combination of ceftolozane (a
novel
...
”
Read Now
8
Ceftolozane and tazobactam for the treatment of bacterial infections : a review of clinical effectiveness, cost-effectiveness, and guidelines
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... recently developed antimicrobia l therapy is the fixed-dose combination of ceftolozane (a
novel
...
”
Read Now
9
Non-invasive prenatal testing : a review of the cost effectiveness and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... sampling (CVS). Recently, a
novel
prenatal testing method has become available. This method, known as non...
”
Read Now
10
Non-invasive prenatal testing : a review of the cost effectiveness and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... sampling (CVS). Recently, a
novel
prenatal testing method has become available. This method, known as non...
”
Read Now
11
Treatments for patients with genotype 1 chronic hepatitis C : a review of evidence-based guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... sofosbuvir employs a
novel
mechanism of action targeting an HCV polymerase and is approved for the treatment...
”
Read Now
12
Treatments for patients with genotype 1 chronic hepatitis C : a review of evidence-based guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... sofosbuvir employs a
novel
mechanism of action targeting an HCV polymerase and is approved for the treatment...
”
Read Now
13
Interferon-free regimens for genotype 1 chronic hepatitis C : a review of the clinical evidence and cost-effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
..., seizures, weight loss, peripheral neuropathy, and bone marrow suppression. A number of
novel
DAA regimens...
”
Read Now
14
Aflibercept (Eylea) : treatment of neovascular (wet) age-related macular degeneration (wAMD)
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
15
Aflibercept (Eylea) : treatment of neovascular (wet) age-related macular degeneration (wAMD)
Published 2015
Canadian Agency for Drugs and Technologies in Health
Read Now
16
Interferon-free regimens for genotype 1 chronic hepatitis C : a review of the clinical evidence and cost-effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
..., seizures, weight loss, peripheral neuropathy, and bone marrow suppression. A number of
novel
DAA regimens...
”
Read Now
17
Intravenous ketamine for the treatment of mental health disorders : a review of clinical effectiveness and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
13
330 - Economics
4
580 - Plants (Botany)
2
700 - The arts; fine & decorative arts
2
Language
English
17
Collection
National Center for Biotechnology Information
17
Author
Canadian Agency for Drugs and Technologies in Health
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
4
Recently Uploaded
Last Month
3
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%28%22novell%22+OR+%22novelle%22%29&type=AllFields
Send by Email
×
Loading...